ECOR Stock Analysis: Buy, Sell, or Hold?
ECOR - electroCore, Inc. Common Stock
$6.80
0.20 (3.03%)
▲
5d:
+12.96%
30d:
-14.73%
90d:
+51.62%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When ECOR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ECOR shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ECOR shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ECOR is currently trading at $6.80, which is considered fair relative to its 30-day fair value range of $6.10 to $7.34.
Technical Outlook: Technically, ECOR is in a uptrend. The price is approaching resistance at $6.98. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.80 (+191.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ECOR is in a uptrend. The price is approaching resistance at $6.98. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.80 (+191.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$6.10 -
$7.34
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.0%)
- BULLISH: Trading 191.2% below Wall St target ($19.80)
Fair Price Analysis
30-Day Fair Range
$6.10 -
$7.34
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$5.56
Resistance Level
$6.98
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.66
Wall Street Target
$19.80
(+191.2%)
Revenue Growth (YoY)
31.2%
Profit Margin
-43.6%
Share & Embed Analysis
Last updated: April 03, 2026 1:12 AM ET
Data refreshes hourly during market hours. Next update: 2:12 AM
Data refreshes hourly during market hours. Next update: 2:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ECOR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua S Lev
SELL
2500 shares
2025-12-04
Daniel S Goldberger
BUY
1000 shares
2025-12-02
Joshua S Lev
SELL
2166 shares
2025-11-12
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
